Search for: "ORTHO-MCNEIL V MYLAN LABS"
Results 1 - 20
of 40
Sort by Relevance
|
Sort by Date
17 Jul 2017, 9:41 am
Clontech Labs., Inc., 224F.3d 1320, 1325 (Fed. [read post]
18 Jul 2014, 11:55 am
Clay v. [read post]
21 Apr 2014, 7:57 pm
”Ortho-McNeil Pharm., Inc. v. [read post]
28 Aug 2013, 10:31 am
See Rolls–Royce PLC v. [read post]
14 Nov 2012, 1:51 pm
See Ortho-McNeil Pharm., Inc. v. [read post]
9 Aug 2012, 5:00 am
Ortho-McNeil (?) [read post]
3 Jun 2012, 12:17 pm
" Ortho-McNeil Pharm. [read post]
2 Mar 2012, 6:52 am
Ortho-McNeil (?) [read post]
28 Oct 2011, 7:00 am
SK & F Lab Co., 702 F. [read post]
27 Aug 2011, 7:55 pm
Ortho-McNeil Pharm., Inc. [read post]
24 Sep 2010, 1:15 pm
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
9 Sep 2010, 7:09 pm
See Ortho-McNeil Pharm., Inc. v. [read post]
2 Sep 2010, 10:51 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Namenda (Memantine) – US: Mylan announces settlement agreement with Forest Lab’s and Merz Pharmaceuticals (SmartBrief) Olux-E (Clobetasol) – US: Patent infringement complaint following a Paragraph IV certification: Stiefel Laboratories Inc. et al. v. [read post]
8 Jun 2010, 11:05 pm
" Ortho-McNeil Pharm., Inc. v. [read post]
3 May 2010, 5:08 pm
” Ortho-McNeil Pharm., Inc. v. [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
5 Mar 2010, 9:10 pm
Cir. 2007); see also Ortho-McNeil Pharm., Inc. v. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
